Skip to main content
Top
Published in: Journal of General Internal Medicine 8/2010

01-08-2010 | Original Article

A Transitional Opioid Program to Engage Hospitalized Drug Users

Authors: Christopher W. Shanahan, MD, MPH, Donna Beers, RN, BSN, CARN, Daniel P. Alford, MD, MPH, Eileen Brigandi, Jeffrey H. Samet, MD, MA, MPH

Published in: Journal of General Internal Medicine | Issue 8/2010

Login to get access

Abstract

BACKGROUND

Many opioid-dependent patients do not receive care for addiction issues when hospitalized for other medical problems. Based on 3 years of clinical practice, we report the Transitional Opioid Program (TOP) experience using hospitalization as a “reachable moment” to identify and link opioid-dependent persons to addiction treatment from medical care.

METHODS

A program nurse identified, assessed, and enrolled hospitalized, out-of-treatment opioid-dependent drug users based on their receipt of methadone during hospitalization. At discharge, patients transitioned to an outpatient interim opioid agonist program providing 30-day stabilization followed by 60-day taper. The nurse provided case management emphasizing HIV risk reduction, health education, counseling, and medical follow-up. Treatment outcomes included opioid agonist stabilization then taper or transfer to long-term opioid agonist treatment.

RESULTS

From January 2002 to January 2005, 362 unique hospitalized, opioid-dependent drug users were screened; 56% (n = 203) met eligibility criteria and enrolled into the program. Subsequently, 82% (167/203) presented to the program clinic post-hospital discharge; for 59% (119/203) treatment was provided, for 26% (52/203) treatment was not provided, and for 16% (32/203) treatment was not possible (pursuit of TOP objectives precluded by medical problems, psychiatric issues, or incarceration). Program patients adhered to a spectrum of medical recommendations (e.g., obtaining prescription medications, medical follow-up).

CONCLUSIONS

The Transitional Opioid Program (TOP) identified at-risk hospitalized, out-of-treatment opioid-dependent drug users and, by offering a range of treatment intensity options, engaged a majority into addiction treatment. Hospitalization can be a “reachable moment” to engage and link drug users into addiction treatment.
Literature
1.
go back to reference Samet JH, Shevitz A, Fowle J, Singer DE. Hospitalization decision in febrile intravenous drug users. Am J Med. 1990;89(1):53–7.CrossRefPubMed Samet JH, Shevitz A, Fowle J, Singer DE. Hospitalization decision in febrile intravenous drug users. Am J Med. 1990;89(1):53–7.CrossRefPubMed
2.
3.
go back to reference Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58(8):729–36.CrossRefPubMed Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58(8):729–36.CrossRefPubMed
4.
go back to reference Hopper JA, Shafi T. Management of the hospitalized injection drug user. Infect Dis Clin North Am. 2002;16(3):571–87.CrossRefPubMed Hopper JA, Shafi T. Management of the hospitalized injection drug user. Infect Dis Clin North Am. 2002;16(3):571–87.CrossRefPubMed
5.
go back to reference McCoy CB, Metsch LR, Chitwood DD, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse. 2001;36(6–7):789–806.CrossRefPubMed McCoy CB, Metsch LR, Chitwood DD, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse. 2001;36(6–7):789–806.CrossRefPubMed
6.
go back to reference Chutuape MA, Jasinski DR, Fingerhood MI, Stitzer ML. One-, 3-, and 6-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse. 2001;27(1):19–44.CrossRefPubMed Chutuape MA, Jasinski DR, Fingerhood MI, Stitzer ML. One-, 3-, and 6-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse. 2001;27(1):19–44.CrossRefPubMed
7.
go back to reference Samet JH, Rollnick S, Barnes H. Beyond CAGE. A brief clinical approach after detection of substance abuse. Arch Intern Med. 1996;156(20):2287–93.CrossRefPubMed Samet JH, Rollnick S, Barnes H. Beyond CAGE. A brief clinical approach after detection of substance abuse. Arch Intern Med. 1996;156(20):2287–93.CrossRefPubMed
8.
go back to reference O'Toole TP, Pollini RA, Ford D, Bigelow G. Physical health as a motivator for substance abuse treatment among medically ill adults: is it enough to keep them in treatment? J Subst Abuse Treat. 2006;31(2):143–50.CrossRefPubMed O'Toole TP, Pollini RA, Ford D, Bigelow G. Physical health as a motivator for substance abuse treatment among medically ill adults: is it enough to keep them in treatment? J Subst Abuse Treat. 2006;31(2):143–50.CrossRefPubMed
9.
go back to reference O'Connor PG, Samet JH, Stein MD. Management of hospitalized intravenous drug users: role of the internist. Am J Med. 1994;96(6):551–8.CrossRefPubMed O'Connor PG, Samet JH, Stein MD. Management of hospitalized intravenous drug users: role of the internist. Am J Med. 1994;96(6):551–8.CrossRefPubMed
10.
go back to reference Chan AC, Palepu A, Guh DP, et al. HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support. J Acquir Immune Defic Syndr. 2004;35(1):56–9.CrossRefPubMed Chan AC, Palepu A, Guh DP, et al. HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support. J Acquir Immune Defic Syndr. 2004;35(1):56–9.CrossRefPubMed
11.
go back to reference Simpson DD, Savage LJ. Treatment re-entry and outcomes of opioid addicts during a 4-year follow-up after drug abuse treatment in the United States. Bull Narc. 1980;32(4):1–10.PubMed Simpson DD, Savage LJ. Treatment re-entry and outcomes of opioid addicts during a 4-year follow-up after drug abuse treatment in the United States. Bull Narc. 1980;32(4):1–10.PubMed
12.
go back to reference Simpson DD. Treatment for drug abuse. Follow-up outcomes and length of time spent. Arch Gen Psychiatry. 1981;38(8):875–80.PubMed Simpson DD. Treatment for drug abuse. Follow-up outcomes and length of time spent. Arch Gen Psychiatry. 1981;38(8):875–80.PubMed
13.
go back to reference Aszalos R, McDuff D, Weintraub E, Montoya I, Schwartz R. Engaging hospitalized heroin-dependent patients into substance abuse treatment. J Subst Abuse Treat. 1999;17(1–2):149–158.CrossRefPubMed Aszalos R, McDuff D, Weintraub E, Montoya I, Schwartz R. Engaging hospitalized heroin-dependent patients into substance abuse treatment. J Subst Abuse Treat. 1999;17(1–2):149–158.CrossRefPubMed
14.
go back to reference O'Toole TP, Pollini RA, Ford DE, Bigelow G. The effect of integrated medical-substance abuse treatment during an acute illness on subsequent health services utilization. Med Care. 2007;45(11):1110–5.CrossRefPubMed O'Toole TP, Pollini RA, Ford DE, Bigelow G. The effect of integrated medical-substance abuse treatment during an acute illness on subsequent health services utilization. Med Care. 2007;45(11):1110–5.CrossRefPubMed
15.
go back to reference O'Toole TP, Conde-Martel A, Young JH, Price J, Bigelow G, Ford DE. Managing acutely ill substance-abusing patients in an integrated day hospital outpatient program: medical therapies, complications, and overall treatment outcomes. J Gen Intern Med. 2006;21(6):570–6.CrossRefPubMed O'Toole TP, Conde-Martel A, Young JH, Price J, Bigelow G, Ford DE. Managing acutely ill substance-abusing patients in an integrated day hospital outpatient program: medical therapies, complications, and overall treatment outcomes. J Gen Intern Med. 2006;21(6):570–6.CrossRefPubMed
16.
go back to reference Sears C, Guydish JR, Weltzien EK, Lum PJ. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U.S.A. J Acquir Immune Defic Syndr. 2001;27(2):193–201.PubMed Sears C, Guydish JR, Weltzien EK, Lum PJ. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U.S.A. J Acquir Immune Defic Syndr. 2001;27(2):193–201.PubMed
17.
go back to reference Bortolotti F, Stivanello A, Dall'Armi A, Rinaldi R, La Grasta F. AIDS information campaign has significantly reduced risk factors for HIV infection in Italian drug abusers. J Acquir Immune Defic Syndr. 1988;1(4):412–3.PubMed Bortolotti F, Stivanello A, Dall'Armi A, Rinaldi R, La Grasta F. AIDS information campaign has significantly reduced risk factors for HIV infection in Italian drug abusers. J Acquir Immune Defic Syndr. 1988;1(4):412–3.PubMed
18.
go back to reference Friedman SR, Des Jarlais DC, Sotheran JL. AIDS health education for intravenous drug users. Health Educ Q. 1986;13(4):383–93.PubMed Friedman SR, Des Jarlais DC, Sotheran JL. AIDS health education for intravenous drug users. Health Educ Q. 1986;13(4):383–93.PubMed
19.
go back to reference Institute of Medicine. A frame work for improving quality. In: Improving the Quality of Health Care for Mental and Substance-use Conditions, ed. Quality Chasm Series. Washington: National Academy Press; 2006:56–76. Institute of Medicine. A frame work for improving quality. In: Improving the Quality of Health Care for Mental and Substance-use Conditions, ed. Quality Chasm Series. Washington: National Academy Press; 2006:56–76.
20.
go back to reference Miller WR, Rollnick S. Phase 2: Strengthening commitment to change. In: Motivational Interviewing, ed. Preparing People for Change. New York: Guilford Press; 2002:428. Miller WR, Rollnick S. Phase 2: Strengthening commitment to change. In: Motivational Interviewing, ed. Preparing People for Change. New York: Guilford Press; 2002:428.
21.
go back to reference Marlett GA. Harm reduction around the world: a brief history. In: Marlett GA, ed. Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors. New York: Guilford Press; 1998:390. Marlett GA. Harm reduction around the world: a brief history. In: Marlett GA, ed. Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors. New York: Guilford Press; 1998:390.
22.
go back to reference Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992;47(9):1102–14.CrossRefPubMed Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol. 1992;47(9):1102–14.CrossRefPubMed
23.
go back to reference Marlatt GA. Basic principles and strategies of harm reduction. In: Marlatt GA, ed. Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors. New York: The Guilford Press; 1998:50–52. Marlatt GA. Basic principles and strategies of harm reduction. In: Marlatt GA, ed. Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors. New York: The Guilford Press; 1998:50–52.
24.
go back to reference Federal Register, title 21, 1993. Codified at 58 CFR 496, pt 291. Federal Register, title 21, 1993. Codified at 58 CFR 496, pt 291.
25.
go back to reference Sorensen JL, Masson CL, Delucchi K, et al. Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol. 2005;73(6):1026–35.CrossRefPubMed Sorensen JL, Masson CL, Delucchi K, et al. Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol. 2005;73(6):1026–35.CrossRefPubMed
26.
go back to reference Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: health care use and costs 6 months after randomization. Addiction. 2006;101(12):1797–1804.CrossRefPubMed Barnett PG, Masson CL, Sorensen JL, Wong W, Hall S. Linking opioid-dependent hospital patients to drug treatment: health care use and costs 6 months after randomization. Addiction. 2006;101(12):1797–1804.CrossRefPubMed
27.
go back to reference Schwartz RP, Highfield DA, Jaffe JH, et al. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry. 2006;63(1):102–9.CrossRefPubMed Schwartz RP, Highfield DA, Jaffe JH, et al. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry. 2006;63(1):102–9.CrossRefPubMed
28.
go back to reference Schwartz RP, Jaffe JH, Highfield DA, Callaman JM, O'Grady KE. A randomized controlled trial of interim methadone maintenance: 10-month follow-up. Drug Alcohol Depend. 2007;86(1):30–6.CrossRefPubMed Schwartz RP, Jaffe JH, Highfield DA, Callaman JM, O'Grady KE. A randomized controlled trial of interim methadone maintenance: 10-month follow-up. Drug Alcohol Depend. 2007;86(1):30–6.CrossRefPubMed
Metadata
Title
A Transitional Opioid Program to Engage Hospitalized Drug Users
Authors
Christopher W. Shanahan, MD, MPH
Donna Beers, RN, BSN, CARN
Daniel P. Alford, MD, MPH
Eileen Brigandi
Jeffrey H. Samet, MD, MA, MPH
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 8/2010
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1311-3

Other articles of this Issue 8/2010

Journal of General Internal Medicine 8/2010 Go to the issue

Healing Arts: Materia Medica

One Day Later

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.